IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.

Ikink GJ, Boer M, Bakker ER, Hilkens J
Nat Commun. 2016 Nov 23;7:13567. doi: 10.1038/ncomms13567. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.